Skip to main content
. 2008 Jun;35(3):179–192. doi: 10.1111/j.1744-313X.2008.00765.x

Figure 6.

Figure 6

Synergy of HLA-KIR (human leucocyte antigen-killer immunoglobulin receptor) compound genotypes and duality between autoimmunity and infection. The general paradigm for HLA-KIR epistasis based on current disease association studies. Different HLA-KIR combinations provide different levels of activation and inhibition of NK (natural killer) and T cells resulting in differing susceptibility and protection against infection and autoimmunity.